XBI

Alternative ETFs

In Pictures: October’s 10 Worst ETFs

By Tom LydonNovember 1, 2013

Featured

Biotech ETFs: More Tricks Than Treats in October

By Max ChenOctober 31, 2013

Featured

ETF Categories That Just Keep On Winning

By Gary GordonOctober 2, 2013

Featured

A Biotech ETF for Up-and-Coming Drug Developers

By Tom LydonSeptember 5, 2013

Featured

Three ETFs to Play Up-and-Coming Health Care Companies

By Tom LydonSeptember 3, 2013

Featured

Hunting for Bargains in Sector ETFs

By Tom LydonAugust 23, 2013

Featured

Biotech ETFs Shine in July

By Tom LydonAugust 1, 2013

Featured

ETF Performance Report: July

By Tom LydonJuly 31, 2013

Featured

Positive Prognosis for Biotech ETFs

By Tom LydonMay 10, 2013

Featured

Investors Clamor for Generic Drug ETF

By Tom LydonMay 6, 2013

Featured

Why Biotech ETFs are a Top Sector in 2012

By Tom LydonDecember 19, 2012

Featured

Biotech ETFs Holding Up During Rocky November

By Tom LydonNovember 19, 2012

Featured

Election Could Make or Break Health Care ETFs

By Tom LydonSeptember 18, 2012

Featured

Biotech ETFs Cool After Strong Run

By Tom LydonAugust 13, 2012

Featured

Fidelity Active ETFs Would Gain Market Share: S&P

By Tom LydonAugust 10, 2012

ETF of the Week

Tom Lydon, Chuck Jaffe Talk ETF of the Week: Biotechnology

By Tom LydonAugust 2, 2012

Featured

Follow the Next Breakthrough Drug Makers with Biotechnology ETFs

By Tom LydonAugust 2, 2012

Alternative ETFs

Energy ETFs Start Second Half with a Bang

By Tom LydonJuly 3, 2012

Previous 1 … 11 12 13 14 15 16 Next